
|Articles|November 1, 2003
BPH management: New paradigms, new approaches
Author(s)Steven A. Kaplan, MD
The paradigm for the medical management of benign prostatic hyperplasia has undergone a significant change during the past decade. Guided by new research, the approval of novel pharmaceutical and minimally invasive therapies, and the economics of health care financing, physicians have altered their approach to patient care in distinct ways.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
3
FDA grants tentative approval to generic enzalutamide tablets
4
Atish Choudhury, MD, PhD, highlights phase 2 data on treatment interruption in mHSPC
5













